Where does Biomadison, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biomadison, Inc. ranks #9,200 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biomadison, Inc. hold?

Biomadison, Inc. holds 34 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Biomadison, Inc.'s Innovation Score?

Biomadison, Inc. has an Innovation Score of 39.4 out of 100 (top 38% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biomadison, Inc. focus on?

Biomadison, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 32 patents, ranking #475 of 7,863 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Biomadison, Inc.'s patent grant rate increasing or decreasing?

Biomadison, Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Biomadison, Inc.'s patents?

Biomadison, Inc.'s patents average 12.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biomadison, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Biomadison, Inc.

USPTO PatentsView assignee record - 34 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biomadison ranks #9,200 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 11 technology areas.

#9,200
of 49,997 US assignees by volume: Top 38%
by Innovation Score (39.4/100): 12.1
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9200 · US Corporation #9,200 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 34 grants
UPPER-Q #9,200/49,997
PHOTO-FINISH Apollo Endosurgery US
CPC-FOCUS G01N · 11 areas
INNOV-THIN 39.4/100
CLAIMS-RICH 12.1 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Apollo Endosurgery US, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biomadison’s 39.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.3 pts (31%) Velocity 8.1 pts (21%) Breadth 11.7 pts (30%) Claim depth 7.2 pts (18%)

Qualcomm Incorporated · highest

85
Arntz Beteiligungs… · near

39
Biomadison · this assignee

39
Department of… · near

39
Eminent Technology · near

39
Fuji OIL Holdings · near

39
3D Lighting… · lowest

7

What this shows Biomadison's Innovation Score is 39.4/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biomadison?

Each dot is one of Biomadison’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biomadison’s own 12.1 claims/patent is ABOVE the 10.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biomadison vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biomadison's grants concentrate

Biomadison, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 94.1% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2016 (6 grants) versus a trough of 1 in 2015. By volume, Biomadison sits between Apollo Endosurgery US, Inc. and Bayer Oy.

Biomadison's three-year grant acceleration

Biomadison, Inc. shows 11 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Apollo Endosurger…

34
Ariens

34
Asana Biosciences

34
BIG Heart PET

34
Bizlink Internati…

34
Boral IP Holdings…

34
Batesville Servic…

34
Bayer Oy

34
Biomadison ◀

34

What this shows Biomadison holds 34 patents at rank #9,196, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biomadison

By rank, the assignees closest to #9,196 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Biomadison's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Biomadison, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Biomadison ranks #475 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Fuji OIL Holdings Inc. 39 Department of Biotechnology 39 Eminent Electronic Technology Corp. Ltd. 39 Arntz Beteiligungs GmbH & Co. KG 39

Biomadison's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biomadison, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	2.9%
2016	6	17.6%
2017	1	2.9%
2018	2	5.9%
2019	5	14.7%
2020	2	5.9%
2021	2	5.9%
2022	5	14.7%
2023	3	8.8%
2024	3	8.8%
2025partial year	4	11.8%

Which technologies does Biomadison, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 32

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 28

C07K - Peptides 25

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 13

A47C - CHAIRS; SOFAS; Beds 4

C12Y - Enzymes 3

G06T - Image Data Processing OR Generation, IN General 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

B01D - Separation 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biomadison, Inc.'s patent record in context - here's where to go next.

Biomadison, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 94.1% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #9,200 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biomadison, Inc. against Apollo Endosurgery US, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.